Entry Detail



General Information

Database ID:exR0000494
RNA Name:ALDH9A1
RNA Type:mRNA
Chromosome:chr1
Starnd:-
Coordinate:
Start Site(bp):165662216End Site(bp):165698863
External Links:ENSG00000143149



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
FYN
chr6
111660332
111873452
-
NIPSNAP1
chr22
29554808
29581327
-
GSE1
chr16
85169525
85676204
+
KCNMB4
chr12
70366290
70434292
+
RPS15
chr19
1438358
1440494
+
HES1
chr3
194136148
194138732
+
B4GALT6
chr18
31622247
31685836
-
FBRSL1
chr12
132489551
132585188
+
TCF19
chr6
31158547
31167159
+
RABEP2
chr16
28904421
28936526
-
MORF4L2
chrX
103675496
103688158
-
PCK2
chr14
24094053
24110598
+
LRRFIP1
chr2
237627587
237813682
+
SRSF2
chr17
76734115
76737374
-
ITCH
chr20
34363241
34540748
+
ZNF384
chr12
6666477
6689572
-
SPARC
chr5
151661096
151686975
-
CD55
chr1
207321376
207386804
+
ENO1
chr1
8861000
8879190
-
RPS6
chr9
19375715
19380236
-
DDOST
chr1
20651767
20661544
-
SRSF3
chr6
36594353
36605600
+
KHSRP
chr19
6413348
6424794
-
RALY
chr20
33993646
34108308
+
SLC4A8
chr12
51391317
51515763
+
MRRF
chr9
122264603
122331337
+
MCM7
chr7
100092728
100101940
-
DVL3
chr3
184155377
184173614
+
GJA1
chr6
121435595
121449727
+
MTA1
chr14
105419820
105470729
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-92a-3p
chrX
134169544
134169565
-
hsa-miR-1270
chr19
20399320
20399342
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC026740.1
chr5
675826
676616
+
AL139819.1
chr10
100335563
100346390
-
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.